19:I[66739,["/_next/static/chunks/0.3dg.jzl0xwf.js?dpl=dpl_BhmHa8NmNRnoMAUm8Lqp3TPz2qZA","/_next/static/chunks/0qxr~fpya2kw0.js?dpl=dpl_BhmHa8NmNRnoMAUm8Lqp3TPz2qZA","/_next/static/chunks/12wfgjmhh21qu.js?dpl=dpl_BhmHa8NmNRnoMAUm8Lqp3TPz2qZA","/_next/static/chunks/028~snn2srcd-.js?dpl=dpl_BhmHa8NmNRnoMAUm8Lqp3TPz2qZA","/_next/static/chunks/079qbl7l5rd72.js?dpl=dpl_BhmHa8NmNRnoMAUm8Lqp3TPz2qZA","/_next/static/chunks/0hi8o2xq05aig.js?dpl=dpl_BhmHa8NmNRnoMAUm8Lqp3TPz2qZA"],"default"] 1b:I[38632,["/_next/static/chunks/0qqtp3r0h7kah.js?dpl=dpl_BhmHa8NmNRnoMAUm8Lqp3TPz2qZA","/_next/static/chunks/0iukvycbd42rl.js?dpl=dpl_BhmHa8NmNRnoMAUm8Lqp3TPz2qZA"],"IconMark"] 1a:T4a0,

Today, Paul and Mike unpack their opinions about lipids. They talk about true risk for cardiovascular disease, primary versus secondary prevention, lipid lowering drugs, and share their thoughts on a recent podcast episode with Peter Attia.

*Produced by Mountain Valley Media

00:06:08 Blood markers & imaging techniques of metabolic function

00:14:38 Gene mutations

00:20:28 LDL & Plaque burden

00:27:23 Money in statins

00:31:38 Downsides of lowering LDL

01:21:23 The downsides of popular cholesterol lowering drugs

01:41:07 Should we fear heart attacks?

01:45:23 PCSK9 Inhibitors

01:52:43 Risk profile of Statins

01:53:02 Risk vs. reward of Ezetimibe

02:04:02 Primary vs. secondary prevention

Resources:

Debunking Sugar Claims: What Dr. Lustig Got Wrong On The Huberman Podcast:

https://www.youtube.com/watch?v=JcEmSgbMfco&t=2933s

Work With Mike: https://mikefave.com/

250. When You Should Worry About LDL Cholesterol with Mike Fave

Paul Saladino MD podcast

250. When You Should Worry About LDL Cholesterol with Mike Fave